Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NM/Albuquerque
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Albuquerque, NM

Studies commonly pay $75 to $4,500 per completed study

341 clinical trials are currently recruiting participants within 30 miles of Albuquerque. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

341studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Albuquerque right now

Top 25 of 341 recruiting studies, sorted by proximity — each links to its official registry page

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens

Hematologic Tests N/A Interventional 425 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi) · Sponsor: Abbott Point of Care
See eligibility & contact on ClinicalTrials.gov (NCT07287631)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm N/A Interventional 600 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06279013)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
The University of New Mexico Unm Health Sciences Center Hsc — Albuquerque, New Mexico (1.5 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.

Phantom Limb Syndrome With Pain Phase 2, Phase 3 Interventional 30 participants sought
Lisa Feierman MD — Albuquerque, New Mexico (1.5 mi) · Sponsor: The Ketamine Research Foundation
See eligibility & contact on ClinicalTrials.gov (NCT07276542)

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Staphylococcus Aureus Phase 1, Phase 2 Interventional 231 participants sought
Research Site — Albuquerque, New Mexico (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06749457)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

Post-ligation Cardiac Syndrome Phase 3 Interventional 316 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi) · Sponsor: NICHD Neonatal Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06679855)

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

MASLD, Obesity EARLY/Phase 1 Interventional 8 participants sought
University of New Mexico Health Sciences Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: University of New Mexico
See eligibility & contact on ClinicalTrials.gov (NCT06934642)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
R1 Therapeutics Clinical Trial Site — Albuquerque, New Mexico (1.5 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation

DNA Damage, Immune System Disorder Phase 2 Interventional 100 participants sought
University of New Mexico Health Sciences Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: University of New Mexico
See eligibility & contact on ClinicalTrials.gov (NCT03908736)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Phase 1 Interventional 65 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05950464)

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Endometrial Cancer Phase 3 Interventional 1,123 participants sought
University of New Mexico Comprehensive Cancer Center ( Site 6046) — Albuquerque, New Mexico (1.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06952504)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05235165)
Google-rated

Top-rated research centers in Albuquerque

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Albuquerque Clinical Trials

★ 4.9
711 Encino Pl NE, Albuquerque, NM 87102
(505) 224-7407
"This place is a great little gem. Very friendly, helpful and professional. Shout out to Louise who goes out of her way to make you feel welcomed. …"
— EMILY MIERA, 5★

Clinical Research & Osteoporosis Center, Inc.

★ 3.7
300 Oak St NE, Albuquerque, NM 87106
(505) 923-3232
"No wait time<br>The procedure was thoroughly explained. Staff members are very attentive."
— theresa miller, 5★

DM Clinical Research-Albuquerque

★ 4.4
1010 Lead Ave SE Ste 100/200, 300, Albuquerque, NM 87106
(505) 300-5434
"Be wary of this company, I've been finding that in the clinical trial that I'm doing with them I'm not being paid as promised. I've talked to them ab…"
— larry simon, 1★

Velocity Clinical Research

★ 4.4
3901 Carlisle Blvd NE, Albuquerque, NM 87107
(505) 243-1627
"It feels good to contribute to meaningful scientific medical research. Staff are great!"
— Rocky Stone, 5★

UNM Clinical & Translational Science Center (CTSC)

900 Camino de Salud, Albuquerque, NM 87131
(505) 272-4673

UNM Cancer Research Facility

★ 5.0
2325 Camino de Salud, Albuquerque, NM 87131
(505) 272-4946
"***This is not a patient care building. *** If you have an appointment to see a doctor, then it is either in the UNM Hospital next door, or the UNM C…"
— Dan Eastwood, 5★

IMA Clinical Research - Albuquerque

★ 4.2
101 Hospital Loop NE Ste 209, Albuquerque, NM 87109
(505) 848-3773
"Seems like a scam, they made me drive all the way from Santa Fe to tell me I wasn't eligible for any studies. Then they gave me a debit card as payme…"
— Andrew Freye, 1★

Mind Research Network

★ 5.0
Research Participants - east clinic entrance Visitors - north entrance, 1101 Yale Blvd NE, Albuquerque, NM 87106
(505) 272-5028

VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center

★ 4.6 (5 reviews)
2401 Centre Ave SE, Albuquerque, NM 87106
(505) 248-3203
"This is an amazing property with amazing staff great friendly very helpful and controlled access property so if you don't have any reason to be here …"
— Tastic “Skinwalker” Weight, 5★

Clinical trials in Albuquerque: what's recruiting

The Albuquerque area currently has 341 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Albuquerque, the most active research areas are:

  • Cancer & Oncology12 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Albuquerque, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Albuquerque

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Albuquerque participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Albuquerque?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Albuquerque safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Albuquerque, NM?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Albuquerque?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Albuquerque.

Paid clinical trials near Albuquerque

Other metros within reach

Las Cruces, NM16 El Paso, TX190 Colorado Springs, CO207 Grand Junction, CO54 Amarillo, TX94 Lakewood, CO1,599 Denver, CO1,599 Aurora, CO1,563

More of NM

Las Cruces16

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts